B44 C91.0 C92.0
Conditions
Interventions
Group 1: Patients with acute leucemia and proven or probable invasive Aspergillosis according to EORTC/MSG criteria will be documented into a eCRF regarding risc factors, diagnostics, therapy and resu
Sponsors
Klinik I für Innere Medizin
Uniklinik Köln
Bettenhaus, Ebene 15, Raum 64
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with acute leukemia
Exclusion criteria
Exclusion criteria: Patients without acute leukemia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival after 14, 28, 84 days | — |
Secondary
| Measure | Time frame |
|---|---|
| - the development of resistance in Aspergillus spp. identified by microbiological analyses conducted after diagnosis of invasive aspergillosis - efficacy of different therapies against invasive Aspergillosis provided after diagnosis of the disease | — |
Countries
Germany
Contacts
Public ContactMaria Vehreschild
Klinik I für Innere Medizin Uniklinik Köln Bettenhaus, Ebene 15, Raum 64
Outcome results
None listed